Actively Recruiting
Comparison of FDG and FAPI in Patients With Various Types of Cancer
Led by The First Affiliated Hospital of Xiamen University · Updated on 2023-08-08
3000
Participants Needed
1
Research Sites
427 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To evaluate the potential usefulness of 68Ga-DOTA-FAPI-04 positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various types of cancer, compared with 18F-FDG PET/CT.
CONDITIONS
Official Title
Comparison of FDG and FAPI in Patients With Various Types of Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients aged 18 years or older
- Patients with suspected, newly diagnosed, or previously treated malignant tumors confirmed by MRI, CT, tumor markers, or pathology report
- Patients scheduled for both 18F-FDG and 68Ga-DOTA-FAPI-04 PET/CT scans
- Patients able to provide informed consent (signed by participant, parent, or legal representative) and assent as per ethics guidelines
You will not qualify if you...
- Patients with non-malignant lesions
- Pregnant patients
- Patients or their representatives unable or unwilling to provide written informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
First affiliated hospital of xiamen university
Xiamen, Fujian, China, 0086-361000
Actively Recruiting
Research Team
H
Hua Wu, PhD
CONTACT
H
Haojun Chen, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here